Argitalpenak (22) Sergio Mayor Torroglosa argitalpenak

2022

  1. Analysis of the prognostic value of emergency blood tests in ischaemic stroke

    Neurologia

2021

  1. Association of calprotectin with other inflammatory parameters in the prediction of mortality for ischemic stroke

    Journal of Neuroinflammation, Vol. 18, Núm. 1

2020

  1. Circular RNA expression profile in blood according to ischemic stroke etiology

    Cell and Bioscience, Vol. 10, Núm. 1

2018

  1. Mass spectrometry-based proteomic profiling of thrombotic material obtained by endovascular thrombectomy in patients with ischemic stroke

    International Journal of Molecular Sciences, Vol. 19, Núm. 2

2015

  1. Cefalea tipo SUNCT (Short-lasting unilateral neuralgiform headache attack with conjunctival injection and tearing) asociada a lesión hipofisaria

    Neurologia

2014

  1. Infarto cerebral por embolismo cálcico y tratamiento trombolítico ineficaz

    Neurologia

2012

  1. Myasthenic crisis and Takotsubo syndrome: A non-chance relationship

    Revista de Neurologia

  2. Stroke and Takotsubo syndrome: A reciprocal relationship

    Revista de Neurologia, Vol. 55, Núm. 8, pp. 475-478

2011

  1. Reversible Parkinsonism after accidental oral intake of mancozeb

    Movement Disorders

2010

  1. Ocular hypertension impairs optic nerve axonal transport leading to progressive retinal ganglion cell degeneration

    Experimental Eye Research, Vol. 90, Núm. 1, pp. 168-183

2009

  1. A computerized analysis of the entire retinal ganglion cell population and its spatial distribution in adult rats

    Vision Research, Vol. 49, Núm. 1, pp. 115-126

  2. Retinal ganglion cell population in adult albino and pigmented mice: A computerized analysis of the entire population and its spatial distribution

    Vision Research, Vol. 49, Núm. 6, pp. 637-647

2008

  1. Infarto pontino por vasoespasmo seeundario a hemorragia subaracnoidea perimesencefálica

    Neurologia, Vol. 23, Núm. 4, pp. 256-258

2007

  1. Neuroprotection of retinal ganglion cell function and their central nervous system targets

    Eye (Basingstoke), Vol. 21, pp. S42-S45

2006

  1. The growth factor response in ischemic rat retina and superior colliculus after brimonidine pre-treatment

    Brain Research Bulletin, Vol. 71, Núm. 1-3, pp. 208-218

2005

  1. Ischemia results 3 months later in altered ERG, degeneration of inner layers, and deafferented tectum: Neuroprotection with brimonidine

    Investigative Ophthalmology and Visual Science, Vol. 46, Núm. 10, pp. 3825-3835

2003

  1. Transient ischemia of the retina results in massive degeneration of the retinotectal projection: Long-term neuroprotection with brimonidine

    Experimental Neurology, Vol. 184, Núm. 2, pp. 767-777

2002

  1. Neuroprotective effects of brimonidine against transient ischemia-induced retinal ganglion cell death: A dose response in vivo study

    Experimental Eye Research, Vol. 74, Núm. 2, pp. 181-189

  2. Retinal ganglion cell death after acute retinal ischemia is an ongoing process whose severity and duration depends on the duration of the insult

    Neuroscience, Vol. 109, Núm. 1, pp. 157-168

  3. Transient ischemia of the retina results in altered retrograde axoplasmic transport: Neuroprotection with brimonidine

    Experimental Neurology, Vol. 178, Núm. 2, pp. 243-258